Drugs / ALK Alutard timothy
last change Jan 2022 re-read 3 minutes ago

ALK Alutard timothy

Developed for
allergic rhinitis · asthma · conjunctivitis
Investigated by
Karolinska Institutet

Trials 1

2018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT03375775 May 2017 → Jan 2022 allergic rhinitis, asthma, conjunctivitis Karolinska Institutet Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ALK Alutard timothy ClinicalTrials.gov intervention name — accepted as the source's own label NCT03375775 ↗
Route Subcutaneous “Subcutaneous immunotherapy” NCT03375775 ↗